313 related articles for article (PubMed ID: 9241736)
1. The origin of P-selectin as a circulating plasma protein.
Fijnheer R; Frijns CJ; Korteweg J; Rommes H; Peters JH; Sixma JJ; Nieuwenhuis HK
Thromb Haemost; 1997 Jun; 77(6):1081-5. PubMed ID: 9241736
[TBL] [Abstract][Full Text] [Related]
2. [Soluble P-selectin - a marker of platelet activation and vessel wall injury: increase of soluble P-selectin in plasma of patients with myocardial infarction, massive atherosclerosis and primary pulmonary hypertension].
Semenov AV; Kogan-Ponomarev MIa; Ruda MIa; Komarov AL; Panchenko EP; Chazova IE; Mazurov AV
Ter Arkh; 2000; 72(4):15-20. PubMed ID: 10833791
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of P-selectin are determined by platelet turn-over and the P-selectin Thr715Pro polymorphism.
Panzer S; Rosales S; Gisslinger H; Jungbauer L; Kaider A; Knöbl P; Sillaber C; Pabinger I
Thromb Res; 2008; 121(4):573-9. PubMed ID: 17698171
[TBL] [Abstract][Full Text] [Related]
4. Increased P-selectin plasma levels in patients with thrombotic thrombocytopenic purpura.
Vianelli N; Catani L; Gugliotta L; Nocentini F; Baravelli S; Lancellotti G; Tura S
Haematologica; 1996; 81(1):3-7. PubMed ID: 8900845
[TBL] [Abstract][Full Text] [Related]
5. Soluble P-selectin as a marker of platelet hyperactivity in patients with chronic obstructive pulmonary disease.
Ferroni P; Basili S; Martini F; Vieri M; Labbadia G; Cordova C; Alessandri C; Gazzaniga PP
J Investig Med; 2000 Jan; 48(1):21-7. PubMed ID: 10695266
[TBL] [Abstract][Full Text] [Related]
6. Circulating levels of high-sensitivity C-reactive protein and soluble markers of vascular endothelial cell activation in growth hormone-deficient adolescents.
Lanes R; Marcano H; Villaroel O; Gunczler P; Morillo E; Paoli M; Perez M; Maulino N; Palacios A
Horm Res; 2008; 70(4):230-5. PubMed ID: 18772596
[TBL] [Abstract][Full Text] [Related]
7. Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of "healthy control subjects" and "disease control subjects" in sinus rhythm.
Choudhury A; Chung I; Blann AD; Lip GY
J Am Coll Cardiol; 2007 May; 49(19):1957-64. PubMed ID: 17498581
[TBL] [Abstract][Full Text] [Related]
8. Plasma macrophage colony-stimulating factor and P-selectin levels in malaria-associated thrombocytopenia.
Lee SH; Looareesuwan S; Chan J; Wilairatana P; Vanijanonta S; Chong SM; Chong BH
Thromb Haemost; 1997 Feb; 77(2):289-93. PubMed ID: 9157583
[TBL] [Abstract][Full Text] [Related]
9. Levels and value of soluble P-selectin following acute myocardial infarction: evaluating the link between soluble P-selectin levels and recruitment of circulating white blood cells and the marker for the rapid diagnosis of chest pain.
Chiu CA; Wu CJ; Yang CH; Fang CY; Hsieh YK; Hang CL; Hung WC; Chen CJ; Chen SM; Yu TH; Yeh KH; Fu M; Yip HK
Chang Gung Med J; 2005 Oct; 28(10):699-707. PubMed ID: 16382754
[TBL] [Abstract][Full Text] [Related]
10. Production of soluble P-selectin by platelets and endothelial cells.
Semenov AV; Romanov YA; Loktionova SA; Tikhomirov OY; Khachikian MV; Vasil'ev SA; Mazurov AV
Biochemistry (Mosc); 1999 Nov; 64(11):1326-35. PubMed ID: 10611541
[TBL] [Abstract][Full Text] [Related]
11. Microparticle-associated P-selectin reflects platelet activation in preeclampsia.
Lok CA; Nieuwland R; Sturk A; Hau CM; Boer K; Vanbavel E; Vanderpost JA
Platelets; 2007 Feb; 18(1):68-72. PubMed ID: 17365856
[TBL] [Abstract][Full Text] [Related]
12. P-selectin as a circulating molecular marker in rheumatoid arthritis with thrombocytosis.
Ertenli I; Kiraz S; Arici M; Haznedaroglu IC; Calgüneri M; Celik I; Kirazli S
J Rheumatol; 1998 Jun; 25(6):1054-8. PubMed ID: 9632062
[TBL] [Abstract][Full Text] [Related]
13. Changes in platelet CD 62P expression and soluble P-selectin concentration in surgically treated colorectal carcinoma.
Dymicka-Piekarska V; Matowicka-Karna J; Osada J; Kemona H; Butkiewicz AM
Adv Med Sci; 2006; 51():304-8. PubMed ID: 17357330
[TBL] [Abstract][Full Text] [Related]
14. Circulating adhesion molecules in patients with stable coronary artery disease.
Atalar E; Haznedaroğlu Y; Aytemir K; Ozer N; Aksöyek S; Ovünç K; Kirazly S; Ozmen F
Int J Hematol; 2000 Dec; 72(4):507-11. PubMed ID: 11197222
[TBL] [Abstract][Full Text] [Related]
15. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Spencer CG; Martin SC; Felmeden DC; Blann AD; Beevers GD; Lip GY
Int J Cardiol; 2004 Apr; 94(2-3):293-300. PubMed ID: 15093996
[TBL] [Abstract][Full Text] [Related]
16. Soluble P-selectin concentration in patients with colorectal cancer.
Dymicka-Piekarska V; Butkiewicz A; Matowicka-Karna J; Kemona H
Neoplasma; 2005; 52(4):297-301. PubMed ID: 16059645
[TBL] [Abstract][Full Text] [Related]
17. Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure.
Chung I; Choudhury A; Patel J; Lip GY
Ann Med; 2009; 41(1):45-51. PubMed ID: 18618353
[TBL] [Abstract][Full Text] [Related]
18. Platelet indexes in relation to target organ damage in high-risk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Nadar SK; Blann AD; Kamath S; Beevers DG; Lip GY
J Am Coll Cardiol; 2004 Jul; 44(2):415-22. PubMed ID: 15261941
[TBL] [Abstract][Full Text] [Related]
19. Effect of tumor stage and nephrectomy on CD62P expression and sP-selectin concentration in renal cancer.
Mantur M; Kemona H; Kozłowski R; Kemona-Chetnik I
Neoplasma; 2003; 50(4):262-5. PubMed ID: 12937838
[TBL] [Abstract][Full Text] [Related]
20. Soluble P selectin levels in chronic liver disease: relationship to disease severity.
Vardareli E; Saricam T; Demirustu C; Gulbas Z
Hepatogastroenterology; 2007 Mar; 54(74):466-9. PubMed ID: 17523300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
